Skip to content

Issue 10-27-2014

Other issues take precedence over selling

exactly. Rather, the issue is that retailing, just prior to the Christmas selling season, has become dangerously internalized — and socialized. The talk these days is all about individual companies and the issues that surround them. Perhaps more ominous, much of the discussion revolves around social

A look at the Harvoni/Sovaldi conundrum

Gilead Sciences and its breakthrough work in developing treatments for hepatitis C, the frequently devastating liver disease, have in recent months become the focal point of the debate about the cost and benefits of pharmaceutical products.

For consumers, value, not price, is paramount factor

In a multipart series throughout 2014, our team is examining key product attributes and marketing tactics from two different perspectives: the retail buyer and the consumer/shopper. This objective picture of the two viewpoints should contribute to a product’s success at retail.